Michael Aaron Kelly - Insider Trading & Ownership

Entity
Individual
Location
C/O Hookipa Pharma Inc., 430 East 29 Th St., New York, New York
Summary
The estimated net worth of Michael Aaron Kelly is at least $1.94 M dollars as of June 14, 2024. Michael Aaron Kelly is the Director of NEOGENOMICS INC and owns shares of NEOGENOMICS INC (NEO) stock worth about $895 K. Michael Aaron Kelly is the Director of AMICUS THERAPEUTICS, INC. and owns shares of AMICUS THERAPEUTICS, INC. (FOLD) stock worth about $521 K. Michael Aaron Kelly is the Director of DMC Global Inc. and owns shares of DMC Global Inc. (BOOM) stock worth about $448 K. Michael Aaron Kelly is the Director of HOOKIPA Pharma Inc. and owns shares of HOOKIPA Pharma Inc. (HOOK) stock worth about $60 K. Michael Aaron Kelly is the Director of Aprea Therapeutics, Inc. and owns shares of Aprea Therapeutics, Inc. (APRE) stock worth about $17 K.
All Insider Reports
All Insider Reports

Ownership of Michael Aaron Kelly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NEO NEOGENOMICS INC Director $895 K Jun 1, 2024
FOLD AMICUS THERAPEUTICS, INC. Director $521 K Jun 6, 2024
BOOM DMC Global Inc. Director $448 K May 15, 2024
HOOK HOOKIPA Pharma Inc. Director $60 K Jun 30, 2022
APRE Aprea Therapeutics, Inc. Director $17 K Jun 30, 2021
PRME Prime Medicine, Inc. Director Jun 12, 2024

Insider Transactions Reported by Michael Aaron Kelly:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership